Evome Medical Technologies Inc.
Evome Medical Technologies Inc. designs, develops, produces, and sells medical devices in the United States. The company was formerly known as Salona Global Medical Device Corporation and changed its name to Evome Medical Technologies Inc. in January 2024. The company is based in Shirley, New York.
Evome Medical Technologies Inc. (EVMT) - Total Liabilities
Latest total liabilities as of August 2024: CA$38.56 Million CAD
Based on the latest financial reports, Evome Medical Technologies Inc. (EVMT) has total liabilities worth CA$38.56 Million CAD as of August 2024.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Evome Medical Technologies Inc. - Total Liabilities Trend (2019–2023)
This chart illustrates how Evome Medical Technologies Inc.'s total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Evome Medical Technologies Inc. Competitors by Total Liabilities
The table below lists competitors of Evome Medical Technologies Inc. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Averbuch Formica Center Ltd
TA:AVER
|
Israel | ILA30.26 Million |
|
Utron Ltd
TA:UTRN
|
Israel | ILA72.11 Million |
|
Siwani Makmur Tbk
JK:SIMA
|
Indonesia | Rp261.72 Billion |
|
TAKEDA PHARMA (TKD.SG)
STU:TKD
|
Germany | €7.65 Trillion |
|
Albaraka Turk Katilim Bankasi AS
IS:ALBRK
|
Turkey | TL397.50 Billion |
|
Capitan Investment Ltd
V:CAI
|
Canada | CA$1.24 Million |
|
Nate's Food Co
PINK:NHMD
|
USA | $1.63 Million |
|
Neste Corp
STU:NEF
|
Germany | €8.85 Billion |
Liability Composition Analysis (2019–2023)
This chart breaks down Evome Medical Technologies Inc.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.51 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -11.24 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 1.10 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Evome Medical Technologies Inc.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Evome Medical Technologies Inc. (2019–2023)
The table below shows the annual total liabilities of Evome Medical Technologies Inc. from 2019 to 2023.
| Year | Total Liabilities | Change |
|---|---|---|
| 2023-11-30 | CA$44.25 Million | +49.87% |
| 2021-11-30 | CA$29.53 Million | +355.11% |
| 2020-11-30 | CA$6.49 Million | +2690.80% |
| 2019-11-30 | CA$232.48K | -- |